Drugs
Conditions
News and resources
MIMS Supported ResourcesAll pholcodine products to be withdrawn in EU
The European Medicines Agency (EMA) has recommended that patients be advised to stop taking pholcodine-containing medicines after the drug was found to increase the risk of anaphylactic reactions to general anasthesia.
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.